Loading stock data…
Option Care Health (OPCH)
$21.32-0.50 (-2.29%)
Market ClosedLast close Jun 29
Option Care Health, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Option Care Health, Inc. in the Healthcare sector is trading at $21.32 with a market capitalization of $3.4B. Wall Street consensus targets $28.58 (12 analysts), implying a +34.1% move over the next 12 months. The stock is currently near its 52-week low of $18.01, remaining 24.8% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +34.1% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.35B↓ | $1.47B↑ | $1.44B↑ | $1.42B↑ | $1.33B |
| Gross Profit | $262.01M↓ | $282.90M↑ | $272.90M↑ | $269.04M↑ | $263.05M |
| Operating Income | $72.55M↓ | $91.50M↑ | $84.51M↑ | $82.71M↑ | $79.19M |
| Net Income | $45.34M↓ | $58.50M↑ | $51.82M↑ | $50.52M↑ | $46.74M |
Peer Comparison
JNJUNHPFE
Fundamentals
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition s...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$3.39B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
15.26%
Volume
Today's trading volume
2.60M
Recent News
Is Option Care Health, Inc. (OPCH) A Good Stock To Buy Now?
Is OPCH a good stock to buy? We came across a bullish thesis on Option Care Health, Inc. on r/ValueInvesting by Unusual_Reveal_8569. In this article, we will summarize the bulls’ thesis on OPCH. Option Care Health, Inc.’s share was trading at $21.99 as of June 18th. OPCH’s trailing and forward P/E were 17.16 and 12.35 respectively according […]
Should Goldman’s Neutral Stance Amid Slower Growth Shift How OPCH Investors View Its Home-Infusion Moat?
Earlier in June 2026, Goldman Sachs initiated coverage on Option Care Health with a Neutral rating, highlighting long-term specialty infusion demand alongside near-term earnings uncertainty tied to therapy-specific disruptions in its chronic portfolio. This new coverage arrives after weak first-quarter results, reduced full-year revenue guidance, and a recent downgrade from Bank of America, sharpening investor focus on how slowing growth, tougher insurance approvals, and rising competition...
Option Care Health (OPCH) Stock Trades Up, Here Is Why
Shares of alternate site health provider Option Care Health (NASDAQ:OPCH) jumped 3.7% in the morning session after Goldman Sachs initiated coverage on the stock with a Neutral rating and a $22 price target.
Billionaire Stanley Druckenmiller’s Long-Term Healthcare Stock Pick: Option Care Health (OPCH)
We just covered the 10 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller. Option Care Health (NASDAQ:OPCH) ranks #6 (see 5 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller). Druckenmiller’s Stake: $50,301,000 Option Care Health (NASDAQ:OPCH) provides home and outpatient infusion therapy services. It delivers medications like antibiotics and immune therapies […]
2 Reasons to Sell OPCH and 1 Stock to Buy Instead
Shareholders of Option Care Health would probably like to forget the past six months even happened. The stock dropped 32.6% and now trades at $20.85. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.